Literature DB >> 402426

Bactericidal antibody in genital infection due to Neisseria gonorrhoeae.

D L Kasper, P A Rice, W M McCormick.   

Abstract

An assay of bactericidial antibody has been developed to study the host response to infection with Neisseria gonorrhoeae. This test for antibody was performed on the sera of women who were exposed to N. gonorrhoeae but who did not become infected, of patients with various types of genital infection with N. gonorrhoeae, and of a small number of individuals with no history of gonorrhea. Antibody was found in the sera of less than 31% of men and women with uncomplicated gonococcal infection. Prolonged mucosal infection with the gonococcus (greater than 33 days) correlated with the presence of bactericidal antibody. Bactericidal antibody was not detected in 95% of the specimens of acute-phase serum obtained from women with gonococcal pelvic inflammatory disease. The convalescent-phase sera of 70% of women with clinically severe pelvic inflammatory disease showed a rise in titer of bactericidal antibody to the infecting strain of N. gonorrhoeae, whereas only 11% of the convalescent-phase sera of women with mild or moderately severe disease showed a similar rise.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402426     DOI: 10.1093/infdis/135.2.243

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Relationship of the interval between infections and the similarity of gonococcal strains in recurrent gonorrhoea.

Authors:  R C Noble; A P Oranje; M F Michel; E Stolz
Journal:  Br J Vener Dis       Date:  1980-02

2.  Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.

Authors:  P A Rice; D L Kasper
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  The bactericidal activity of sera of healthy neonates and of newborns with hyperbilirubinaemia to Escherichia coli.

Authors:  I Miler; J Vondrácek; L Hromádková
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

4.  Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice.

Authors:  Wenxia Song; Sara Condron; Brian T Mocca; Sandra J Veit; Dawn Hill; Asima Abbas; Ann E Jerse
Journal:  Vaccine       Date:  2008-08-30       Impact factor: 3.641

5.  Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis.

Authors:  D L Draper; J F James; G F Brooks; R L Sweet
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

6.  Human seminal plasma inhibition of antibody complement-mediated killing and opsonization of Neisseria gonorrhoeae and other gram-negative organisms.

Authors:  G F Brooks; C J Lammel; B H Petersen; D P Stites
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

7.  Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins.

Authors:  P A Rice; D L Kasper
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

8.  Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. Role of antibodies directed against lipooligosaccharides.

Authors:  P Densen; S Gulati; P A Rice
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

9.  Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.

Authors:  Marisol A Figueira; Sanjay Ram; Richard Goldstein; Derek W Hood; E Richard Moxon; Stephen I Pelton
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

10.  Pore-forming alpha-hemolysin efficiently improves the immunogenicity and protective efficacy of protein antigens.

Authors:  Jin-Tao Zou; Hai-Ming Jing; Yue Yuan; Lang-Huan Lei; Zhi-Fu Chen; Qiang Gou; Qing-Shan Xiong; Xiao-Li Zhang; Zhuo Zhao; Xiao-Kai Zhang; Hao Zeng; Quan-Ming Zou; Jin-Yong Zhang
Journal:  PLoS Pathog       Date:  2021-07-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.